LC4-18730-19073
3 vaccinations
5 coded responses
16 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 900 / CA
- Registered
- 2021-04-18
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Dose 1 — Pfizer-BioNTech
-
2021-03-24
Dose 2 — Pfizer-BioNTech
-
2021-04-18
Registered in v-safe
- 2021-04-18
- 2021-04-30
-
2021-05-05
Survey response — day 42, dose 2MedDRA: Fatigue, Headache, Menstrual disorder, Pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Overall exhaustion, disrupted periods, hormonal changes, headaches and body aches.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-23
-
2021-09-23
Survey response — 6 months, dose 2MedDRA: Decreased appetite, Depression, Fatigue, Headache, Menstruation irregular — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: wonky periods. Exhaustion. depression. headaches. loss of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-09-23
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-09-28
- 2021-10-01
-
2022-02-04
Dose 3 — Moderna
- 2022-02-04
-
2022-02-05
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, VomitingAdult check-in
-
2022-02-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-02-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-02-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-02-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-11
Health check-in — day 7, dose 3Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-18
Survey response — day 14, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to work or attend schoolFree text: Exhaustion.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-27
-
2022-03-17
Survey response — day 35, dose 3MedDRA: Fatigue — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Exhaustion wiped outMedDRA releases: 2024-11 · check-in free text available
-
2023-02-05
Survey response — 12 months, dose 3MedDRA: Dyspnoea, Rhinorrhoea, Wheezing — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-05
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-02-06
- 2023-02-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2022-02-04 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 8 — day 42, dose 2
Symptoms: Overall exhaustion, disrupted periods, hormonal changes, headaches and body aches.
Release 9 — 6 months, dose 2
Symptoms: wonky periods. Exhaustion. depression. headaches. loss of appetite
Release 11 — day 14, dose 3
Symptoms: Exhaustion.
Release 11 — day 35, dose 3
Symptoms: Exhaustion wiped out
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Decreased appetite | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release